DE602005008946D1 - Medizinische aerosolformulierungen mit verbesserter chemischer stabilität - Google Patents

Medizinische aerosolformulierungen mit verbesserter chemischer stabilität

Info

Publication number
DE602005008946D1
DE602005008946D1 DE602005008946T DE602005008946T DE602005008946D1 DE 602005008946 D1 DE602005008946 D1 DE 602005008946D1 DE 602005008946 T DE602005008946 T DE 602005008946T DE 602005008946 T DE602005008946 T DE 602005008946T DE 602005008946 D1 DE602005008946 D1 DE 602005008946D1
Authority
DE
Germany
Prior art keywords
chemical stability
improved chemical
linking agent
butyl rubber
cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005008946T
Other languages
English (en)
Inventor
Brian Meakin
David Lewis
Robert Johnson
Tanya Church
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Publication of DE602005008946D1 publication Critical patent/DE602005008946D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
DE602005008946T 2004-05-13 2005-02-25 Medizinische aerosolformulierungen mit verbesserter chemischer stabilität Active DE602005008946D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04011425 2004-05-13
PCT/EP2005/002041 WO2005112902A2 (en) 2004-05-13 2005-02-25 Medicinal aerosol formulation products with improved chemical stability

Publications (1)

Publication Number Publication Date
DE602005008946D1 true DE602005008946D1 (de) 2008-09-25

Family

ID=34960892

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005008946T Active DE602005008946D1 (de) 2004-05-13 2005-02-25 Medizinische aerosolformulierungen mit verbesserter chemischer stabilität

Country Status (19)

Country Link
US (1) US20070086953A1 (de)
EP (1) EP1746981B1 (de)
JP (1) JP2007537170A (de)
KR (1) KR20070010159A (de)
CN (1) CN1950075A (de)
AT (1) ATE404185T1 (de)
AU (1) AU2005245248A1 (de)
BR (1) BRPI0510852A (de)
CA (1) CA2565747A1 (de)
DE (1) DE602005008946D1 (de)
EA (1) EA200602112A1 (de)
ES (1) ES2309722T3 (de)
IL (1) IL178739A0 (de)
MA (1) MA28649B1 (de)
MX (1) MXPA06013189A (de)
NO (1) NO20065722L (de)
TN (1) TNSN06334A1 (de)
WO (1) WO2005112902A2 (de)
ZA (1) ZA200608742B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA033228B1 (ru) * 2013-12-30 2019-09-30 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Находящаяся под давлением стабильная аэрозольная композиция комбинации гликопиррония бромида и формотерола в форме раствора
AU2014375301B2 (en) * 2013-12-30 2020-03-26 Chiesi Farmaceutici S.P.A. Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination
CN106620976B (zh) * 2016-12-28 2020-01-07 四川普锐特医药科技有限责任公司 一种丙酸氟替卡松定量吸入气雾剂
GB202001537D0 (en) * 2020-02-05 2020-03-18 Consort Medical Plc Pressurised dispensing container
JP2023546025A (ja) * 2020-10-09 2023-11-01 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧定量吸入器のための医薬製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0015884A (pt) * 2000-05-22 2003-07-08 Chiesi Farma Spa Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
MEP30108A (en) * 2002-03-01 2010-06-10 Chiesi Farmaceutici S P Formoterol superfine formulation
US20040126325A1 (en) * 2002-03-12 2004-07-01 David Lewis Medicinal aerosol solution formulation products with improved chemical stability
AU2003214416A1 (en) * 2002-03-18 2003-09-29 Bespak Plc Seal material for a dispensing apparatus
EP1595531A1 (de) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stabile Arzneimittellösung für Druckdosierinhalatoren
IL177103A0 (en) * 2004-02-27 2006-12-10 Chiesi Farma Spa Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CN101119706B (zh) * 2005-02-25 2013-04-17 奇斯药制品公司 用于加压计量吸入器的包含螯合剂的药物气雾制剂

Also Published As

Publication number Publication date
ZA200608742B (en) 2008-07-30
WO2005112902A3 (en) 2006-05-04
WO2005112902A2 (en) 2005-12-01
TNSN06334A1 (en) 2008-02-22
ATE404185T1 (de) 2008-08-15
EP1746981A2 (de) 2007-01-31
EP1746981B1 (de) 2008-08-13
MA28649B1 (fr) 2007-06-01
MXPA06013189A (es) 2007-02-14
NO20065722L (no) 2006-12-12
BRPI0510852A (pt) 2007-11-27
EA200602112A1 (ru) 2007-04-27
CN1950075A (zh) 2007-04-18
JP2007537170A (ja) 2007-12-20
ES2309722T3 (es) 2008-12-16
IL178739A0 (en) 2007-02-11
US20070086953A1 (en) 2007-04-19
KR20070010159A (ko) 2007-01-22
CA2565747A1 (en) 2005-12-01
AU2005245248A1 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
ES2618829T3 (es) Sello para un aparato dispensador
ATE404185T1 (de) Medizinische aerosolformulierungen mit verbesserter chemischer stabilität
DK0616525T3 (da) Medikamenter
PE20011323A1 (es) Formulaciones farmaceuticas en solucion estable para inhaladores presurizados con medicion de dosis
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
DE60308997D1 (de) Formulierungen zur inhalation
CO5611092A2 (es) Formulacion superfina de formoterol
WO2009090495A3 (en) Oil and liquid silicone foamable carriers and formulations
AR059350A1 (es) Formulacion farmaceutica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva
EA200501363A1 (ru) Состав для ингалятора, выдающего мерную дозу препарата, с использованием гидрофторалканов в качестве пропеллентов
BR0112322A (pt) Nova formulação aerossol contendo uma molécula fluorada polar
BR112019005168A2 (pt) composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente que sofre ou susceptível de sofrer de um distúrbio respiratório, para melhoria da estabilidade de uma composição farmacêutica e do desempenho de aerossolização de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica
ATE539761T1 (de) Mittel für injektionszwecke mit einem antibiotikum und das mittel enthaltende lösung zur injektion
US20050241636A1 (en) Seal material for a dispensing apparatus
PE20011271A1 (es) Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares
JP2024052867A (ja) 加圧分注容器
CL2022000330A1 (es) Composición farmacéutica que contiene un agente antifúngico como ingrediente activo
WO2017021698A1 (en) Seal for a dispensing apparatus
GB2410500A (en) Seal for a pharmaceutical dispensing device
BR0312004A (pt) Composições de aerossol transdérmicas
BRPI0408003A (pt) produtos antiperspirante/desodorizante em aerossol
WO2004103339A3 (en) Improved metered dose inhaler
BR0318167A (pt) formulação de liberação controlada contendo um material hidrofóbico como o agente de liberação controlada
BR0012907A (pt) Agente para o remédio de dano neural, composto contendo nitrogênio, e, composição farmacêutica
BR0303489A (pt) Composição farmacêutica estabilizada de composto flúor-éter e método para inibir a degradação de composto flúor-éter. uso de agente estabilizante para inibir a degradação de composto flúor éter

Legal Events

Date Code Title Description
8364 No opposition during term of opposition